In addition, the combined detection of EFNA1 and MMP13 significantly improves the diagnostic efficiency of GC and early-stage GC, indicating that EFNA1 combined with MMP13 may be an independent tumor marker for GC patients, and the combined detection of the two tumor markers is helpful for the diagnosis of GC. This evidence concerns the gene EFNA1 and gastric cancer.